Back to search

Aspirin-induced increases in soluble IL-1 receptor type II concentrations in vitro and in vivo

Data up to Jan 2025

Published1999
Citations26
References23

Total Citations Per Year

Abstract

References (23)

Inhibition of NF-κB by Sodium Salicylate and Aspirin

1994 • 1,743 citations

Interleukin-1 Receptor Antagonist

1993 • 670 citations

Prostaglandins as endogenous mediators of interleukin 1 production.

1986 • 541 citations

Aspirin as a Therapeutic Agent in Cardiovascular Disease

1997 • 437 citations

The type II ‘decoy’ receptor: A novel regulatory pathway for interleukin 1

1994 • 382 citations

Interleukin-1β in Coronary Arteries of Patients With Ischemic Heart Disease

1996 • 307 citations

Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor.

1996 • 283 citations

Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids.

1994 • 238 citations

Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist.

1995 • 222 citations

Differential Effects of Interleukin-1 Receptor Antagonist and Tumor Necrosis Factor Binding Protein on Fatty-Streak Formation in Apolipoprotein E–Deficient Mice

1998 • 209 citations

Distinct isoforms (COX‐1 and COX‐2) of cyclooxygenase: possible physiological and therapeutic implications

1996 • 208 citations

Antiinflammatory Cytokine Responses during Clinical Sepsis and Experimental Endotoxemia: Sequential Measurements of Plasma Soluble Interleukin (IL)-1 Receptor Type II, IL-10, and IL-13

1997 • 187 citations

Inhibition of Activator Protein 1 Activity and Neoplastic Transformation by Aspirin

1997 • 174 citations

In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: An overview

1997 • 141 citations

Regulated expression and release of the IL-1 decoy receptor in human mononuclear phagocytes.

1996 • 105 citations

Increased soluble interleukin-1 type II receptor concentrations in postoperative patients and in patients with sepsis syndrome

1996 • 98 citations

Keratinocyte expression of the type 2 interleukin 1 receptor mediates local and specific inhibition of interleukin 1-mediated inflammation

1997 • 96 citations

Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells.

1995 • 76 citations

Selective induction of cyclo‐oxygenase‐2 activity in the permanent human endothelial cell line HUV‐EC‐C: biochemical and pharmacological characterization

1997 • 61 citations

TNF-alpha, unlike other pro- and anti-inflammatory cytokines, induces rapid release of the IL-1 type II decoy receptor in human myelomonocytic cells.

1997 • 57 citations

Protein A antibody-capture ELISA (PACE): an ELISA format to avoid denaturation of surface-adsorbed antigens

1993 • 43 citations

DIVERGENT EFFECTS OF LPS ON EXPRESSION OF IL-1 RECEPTOR FAMILY MEMBERS IN MONONUCLEAR PHAGOCYTES IN VITRO AND IN VIVO

1998 • 43 citations

THE COMBINATION OF ENDOTOXIN AND DEXAMETHASONE INDUCES TYPE II INTERLEUKIN 1 RECEPTOR (IL-1r II) IN MONOCYTES: A COMPARISON TO INTERLEUKIN 1β (IL-1β) AND INTERLEUKIN 1 RECEPTOR ANTAGONIST (IL-1ra)

1996 • 31 citations

Cited By (0)

Loading...
Aspirin-induced increases in soluble IL-1 receptor type II concentrations in vitro and in… (1999) – Journal of Leukocyte Biology | Metascience Observatory Explorer